Our work demonstrates that eIF4E phosphorylation is critically involved in chemoresistance and highlights the therapeutic potential of inhibiting MNK kinases to overcome resistance to chemotherapy in breast cancer patients. Here, EIF4E is linked to breast carcinoma.